ArticleFrontiers in endocrinology2026
Central lymph node ratio predicting lateral metastasis in pediatric thyroid cancer: a retrospective study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To explore whether central lymph node ratio (LNR) can be used to predict the lateral lymph node metastasis (LLNM) in pediatric patients with differentiated thyroid carcinoma (DTC) and construct a predictive model. Methods: We reviewed the clinicopathological data of patients with DTC (aged ≤14 years) who had thyroid lobectomy (unilateral or bilateral)and therapeutic central neck dissection (CND) with concurrent or staged lateral neck dissection (LND) from 2015 to 2025. Patients were grouped by LLNM status. Receiver Operating Characteristic Curve (ROC) analysis identified the optimal LNR cutoff. Results: In univariate analysis, central LNR threshold of 0.4 predicts LLNM with a sensitivity of 90.0%, specificity of 76.0%, and OR of 11.374.Multivariate analysis identified central LNR (OR = 3.741), bilaterality (OR=3.850), and ≥4 metastatic central nodes (OR = 4.732) as independent predictors. Conclusion: Central LNR, bilaterality, and ≥4 metastatic central lymph nodes were independent predictors. An LNR ≥0.4 serves as a key indicator for identifying high-risk pediatric DTC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.